Skip to content

Clinical trials

Stomach Neoplasms trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Country / region: India Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20081
20091
20114
20132
20161
20191
20212
20232
20241
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting5
Terminated5
Unknown status3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Asian Institute of Gastroenterology, India2
Aurigene Discovery Technologies Limited2
Hoffmann-La Roche2
Tata Memorial Hospital2
Bristol-Myers Squibb1
Eli Lilly and Company1
Hospital del Rio Hortega1
Jazz Pharmaceuticals1
National Cancer Institute (NCI)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms20
Esophageal Neoplasms4
Colonic Neoplasms3
Adenocarcinoma2
Carcinoma, Non-Small-Cell Lung2
Kidney Neoplasms2
Carcinoma, Transitional Cell1
Gastric Outlet Obstruction1
Neoplasm Metastasis1
Pancreatic Neoplasms1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.